Cellular Biomedicine Group competitors

Cellular Biomedicine Group's competitors include AVEO Pharmaceuticals, Nektar Therapeutics, Clovis Oncology and Infinity Pharmaceuticals
Add company...
Cellular Biomedicine Group
Cellular Biomedicine Group is a clinical-stage biopharmaceutical firm engaged in the development of effective immunotherapies for cancer and stem cell therapies for degenerative diseases.
AVEO Pharmaceuticals
AVEO is a biopharmaceutical company focused on the discovery and development of targeted cancer therapeutics.
Nektar Therapeutics
Nektar Therapeutics is a stage-clinical biopharmaceutical company.
Clovis Oncology
Clovis Oncology is a biopharmaceutical company focused on acquiring, developing and commercializing anti-cancer agents.
Infinity Pharmaceuticals
Infinity Pharmaceuticals engages in the discovery and development of medicines for the treatment of cancer and related conditions.
Founding Date
Founding Date
2009
Founding Date
2001
Founding Date
1990
Founding Date
2009
Founding Date
2000
Type
Type
Public
Type
Public
Type
Public
Type
Public
Type
Public
Tags
Locations
Locations
Cupertino, US HQ
Shanghai, CN
Beijing, CN
Hong Kong , HK
Locations
Cambridge, US HQ
Locations
San Francisco, US HQ
Hyderabad, IN
Huntsville, US
Locations
Boulder, US HQ
Locations
Cambridge, US HQ
Employees
Employees
109
Employees
20
Employees
468
Employees
32718% increase
Employees
23
Valuation ($)
Valuation ($)
292.5 m
Valuation ($)
261.5 m
Valuation ($)
9.7 b
Valuation ($)
2.4 b
Valuation ($)
96.4 m
Facebook likes
Facebook likes
N/A
Facebook likes
445
Facebook likes
N/A
Facebook likes
22
Facebook likes
N/A
Twitter followers
Twitter followers
154
Twitter followers
650
Twitter followers
629
Twitter followers
495
Twitter followers
1.8 k

Financial

Revenue (est.)
Revenue (est.)
$336.8k (FY, 2017)
Revenue (est.)
N/A
Revenue (est.)
$307.7m (FY, 2017)
Revenue (est.)
N/A
Revenue (est.)
N/A
Cost of goods
Cost of goods
$162.2k (FY, 2017)
Cost of goods
N/A
Cost of goods
$30.5m (FY, 2017)
Cost of goods
N/A
Cost of goods
N/A
Gross profit
Gross profit
$174.6k (FY, 2017)
Gross profit
N/A
Gross profit
$277.2m (FY, 2017)
Gross profit
N/A
Gross profit
N/A
Net income
Net income
($25.5m) (FY, 2017)
Net income
($26.9m) (FY, 2016)
Net income
($96.7m) (FY, 2017)
Net income
($346.4m) (FY, 2017)
Net income
($41.8m) (FY, 2017)

Funding

Total funding raised
Total funding raised
N/A
Total funding raised
$ 138.2m
Total funding raised
$ 45m
Total funding raised
$ 357m
Total funding raised
$ 178.5m
For sources of this data, please see the company profileDownload Excel

View company profiles

AVEO Pharmaceuticals
HQ
Cambridge, US
Employees
20

AVEO is a biopharmaceutical company focused on the discovery and development of targeted cancer therapeutics.

View company
Nektar Therapeutics
HQ
San Francisco, US
Employees
468

Nektar Therapeutics is a stage-clinical biopharmaceutical company.

View company
Clovis Oncology
HQ
Boulder, US
Employees
327↑ 18% increase

Clovis Oncology is a biopharmaceutical company focused on acquiring, developing and commercializing anti-cancer agents.

View company
Infinity Pharmaceuticals
HQ
Cambridge, US
Employees
23

Infinity Pharmaceuticals engages in the discovery and development of medicines for the treatment of cancer and related conditions.

View company